Genmab
GMAB
GMAB
212 hedge funds and large institutions have $1.89B invested in Genmab in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 83 increasing their positions, 55 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6.6% more ownership
Funds ownership: 63.76% → 70.37% (+6.6%)
1% more funds holding
Funds holding: 209 → 212 (+3)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
212
Holding in Top 10
1
Calls
$5.96M
Puts
$3.04M
Top Buyers
| 1 | +$160M | |
| 2 | +$134M | |
| 3 | +$26.4M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$18.5M |
| 5 |
HJGA
Hardman Johnston Global Advisors
Stamford,
Connecticut
|
+$13.6M |
Top Sellers
| 1 | -$8.72M | |
| 2 | -$8.45M | |
| 3 | -$8.08M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$7.91M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$5.68M |